Literature DB >> 2174138

Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma.

J M Ahn1, C C Huang, M Abramson.   

Abstract

We previously reported the localization of interleukin 1 in the epithelial layer of human cholesteatomas. On the basis of other studies that showed interleukin 1 can stimulate fibroblasts and macrophages to produce collagenases and prostaglandins, we then proposed that interleukin 1 may play an important role in cholesteatoma-related bone resorption, also. Our immunocytochemical study involving more human cholesteatoma samples revealed the presence of interleukin 1 in bone cells and monocytes in the region of active bone destruction. In the present study, the effect of interleukin 1 on these cells found at the bone resorption site was examined. By radioimmunoassay, interleukin 1 was shown to stimulate the production of prostaglandin E2 by osteoblasts in vitro. Interleukin 1 also promoted the migration and multinucleation of bone marrow-derived monocytes. These osteoclast-like cells formed from monocytes contained tartrate-resistant acid phosphatase, and caused the resorption of the devitalized bone in vitro. Above findings suggest that interleukin 1 could cause the bone destruction in cholesteatomas, not only by stimulating the local bone cells, but also by recruiting monocytes for osteoclastic bone resorption.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174138     DOI: 10.1177/019459989010300403

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  13 in total

1.  Effects of Allergina on the treatment of otitis media with effusions.

Authors:  Hyun-Ja Jeong; Seung-Heon Hong; Sung-Chul Kim; Eun-Jeong Park; Chul-Ho Jang; Kyung-Suk Kim; Hyung-Min Kim
Journal:  Inflammation       Date:  2002-04       Impact factor: 4.092

2.  Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.

Authors:  J Bujía; C Kim; P Ostos; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

3.  Confirmation of mucin in lymphatic vessels of acquired cholesteatoma.

Authors:  Tomoyuki Nagai; Tatsuo Suganuma; Soyuki Ide; Hiroshi Shimoda; Seiji Kato
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-22       Impact factor: 2.503

4.  Platelet-derived growth factor in middle ear cholesteatoma.

Authors:  O Fujioka; C C Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

5.  Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma.

Authors:  Tolgahan Çatlı; Yıldırım Bayazıt; Akın Yılmaz; Adnan Menevşe; Ozan Gökdoğan; Nebil Göksu; Suat Özbilen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-06       Impact factor: 2.503

6.  Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.

Authors:  J Bujia; C Kim; P Ostos-Aumente; J Lopez-Villarejo; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 7.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

8.  Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.

Authors:  H Shinoda; C C Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

9.  Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity.

Authors:  J Bujía; C Kim; P Ostos; H Sudhoff; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

10.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.